Melanoma

 

P001 | What’s the best therapy for treating resected stage III melanoma patients?

Minutilli E, Dummer R, Venier A (Italy, Switzerland)

 

P002 | Tissue prognostic factors in melanoma: expression of B7 family members and death receptors TRAIL-R1 and TRAIL-R2

Aubert-Wastiaux H, Knol AC, Khammari A, Saint-Jean M, Nguyen JM, Dréno B (France)

 

P003 | TLR7 and TLR8 expression by melanoma cells correlates with a better relapse-free survival for stage III melanoma patients

Saint-Jean M, Knol AC, Nguyen JM, Khammari A, Dréno B (France)

 

P004 | Absence of amplification of CD4+CD25high regulatory T cells during in vitro expansion of tumour infiltrating lymphocytes (TIL) in melanoma patients

Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B (France)

 

P005 | Induction of apoptosis by photodynamic reaction with Photofrin in human melanotic melanoma cells (MEWO)

Choromanska A, Saczko J, Kulbacka J, Chwilkowska A, Skolucka N, Drag-Zalesińska M, Wysocka T (Poland)

 

P006 | WIPI-1 as a biomarker of defective autophagy in melanoma

Ellis RA, Armstrong JL, Polson H, Kirkham N, Ness T, Horswell S, Tooze S, Lovat PE (United Kingdom)

 

P007 | Comprehensive analysis of phenotypic risk factors of melanoma in a central European population

Wendt J, Schanab O, Binder M, Pehamberger H, Okamoto I (Austria)

 

P008 | Factors contributing to subsequent melanoma in a central European cohort

Wendt J, Schanab O, Binder M, Pehamberger H, Okamoto I (Austria)

 

P009 | Treatment of lentigo maligna by photodynamic therapy (PDT)

Karam A, Simon M, le Masson G, Misery L (France)

 

P010 | Metronomic oral low-dose temozolomide can prolong survival in stage-IV-melanoma patients

Weinlich G, Metzler M, Eisendle K (Austria)

 

P011 | Tattoos, nevi, melanomas and sentinel lymph nodes: challenges of the future

Varga E, Korom I, Varga J, Kemény L, Oláh J (Hungary)

 

P012 | Different dermoscopic patterns of cutaneous melanoma metastases in the same patient

Giorgione R, Pertusi G, Zavattaro E, Gironi L, Veronese F, Colombo E (Italy)

 

P013 | Wnt-1 reduces VEGF-C expression and lymph-angiogenesis in a melanoma mouse model

Niederleithner H, Tauber S, Heinz M, Bilban M, Pehamberger H, Bracher A, Berger W, Loewe R, Petzelbauer P (Austria)

 

P014 | Orbital myositis associated with ipilimumab

Lecouflet M, Verschoore M, Giard C, Gohier P, Le Corre Y, Milea D, Martin L (France)

 

P015 | Different dosing schedules positively influence the effect of the EGF-receptor inhibitor erlotinib in combination with chemotherapy on malignant melanoma

Schicher N, Jerney W, Pehamberger H, Höller C (Austria)

 

P016 | Intraoperative mapping with isosulfan blue of lymphatic leakage at the time of inguinal lymph node dissection for skin cancer for the prevention of postoperative lymphocele: a single institutional analysis

Nakamura Y, Fujisawa Y, Maruyama H, Kawachi Y, Otsuka F (Japan)

 

P017 | Results of “classical” second line with cytotoxic chemotherapies in metastatic melanoma: a retrospective study

Perrin C, Pracht M, Talour K, Talarmin M, Mesbah H, Adamski H, Lefeuvre-Plesse C, Lesimple T (France)

 

P018 | A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination

Rogel A, Vignard V, Bobinet M, Labarriere N, Lang F (France)

 

P019 | Melanoma in Balkan region: clinicopathological characteristics of 266 patients from the hospital-based registry in Serbia

Kandolf Sekulović L, Radević T, Rajović M, Dinić M, Zolotarevski L, Mijušković Z, Zečević R, Novaković M (Serbia)

 

P020 | Soluble markers for prognostic and therapy monitoring of cutaneous melanoma

Neagu M, Constantin C, Diaconeasa A, Boda D (Romania)

 

P021 | [18F]ICF01006, a highly promising melanoma PET tracer, permitting early detection and monitoring of experimental primary and disseminated melanoma

Rbah L, Vidal A, Auzeloux P, Askienazy S, Miot-Noirault E, Moins N, Chezal JM (France)

 

P022 | An exceedingly rare case of primary rhabdoid melanoma of the urinary bladder

Schindler K, Harmankaya K, Haitel A, Pehamberger H, Kunstfeld R (Austria)

 

P023 | Sentinel lymph node biopsy for melanoma: A single centre observational cohort study from 2002 to 2009

Biver-Dalle C, Puzenat E, Algros MP, Delroeux D, Bouladhour H, Pelletier F, Rioux-Gotta MO, Penz S, Saccomani C, Cunat-Peultier S, Humbert P, Aubin F (France)

 

P024 | Electro-immunotherapy with BCG of superficial in-transit melanoma metastases

Kirov K, Peycheva E, Gavrilova I (Bulgaria)

 

P025 | Melanoma aggressiveness modulation by Annexin A1

Rondepierre F, Trzeciakiewicz A, Boudhraa Z, Joumard L, Bonnet M, Papon J, Chezal JM, Ouchchane L, Franck F, Mansard S, Kanitakis J, Labeille B, Moins N, Perrot JL, Dechelotte P, Miot-Noirault E, Bouchon B, D’Incan M, Degoul F (France)

 

P026 | CpG based nano-particle vaccination of melanoma patients induced strong CD8 memory T-cell responses when adjuvanted with Imiquimod

Goldinger SM, Dummer R, Baumgaertner P, Mihic D, Schwarz K, Kobert N, Hamman-Haenni A, Willers J, Geldhof C, Michielin O, Bachmann MF, Speiser DE (Switzerland)

 

P027 | Subtle dermatoscopic aspects in melanoma

Cosgarea R, Ungureanu L (Romania)

 

P028 | Epidemiology of skin melanoma in Ukraine

Korovin SI, Kukushkina MN, Palivets AY (Ukraine)

 

P029 | Elastography as a new screening tool for metastatic lymph nodes in patients monitored for melanoma

Caudron A, Chassine AF, Arnault JP, Dadban A, Chaby G, Lok C (France)

 

P030 | Lymphedema after node dissection for melanoma

Ručigaj TP, Žunter VT (Slovenia)

 

P031 | Malignant Melanoma with papillary thyroid cancer

Lee JH, Won CY, Kim SY, Kim GM (South Korea)

 

P032 | Indoleamine 2,3 dioxygenase: a new prognostic marker in sentinel lymph nodes of melanoma patients

Speeckaert R, van Geel N, Lambert J, Haspeslagh M, van Gele M, Vermaelen K, Thielemans K, Neyns B, Roche N, Rottey S, Deron P, Speeckaert M, Brochez L (Belgium)

 

P033 | Primary cutaneous melanoma diagnosed in monozygotic twins at the same time and location

Suppa M, Pellegrini C, Kostaki D, Concetta Fargnoli M, Peris K (Italy)

 

P034 | Single-institution experience in an extended access program with the CTLA-4 blocking monoclonal antibody ipilimumab in pretreated melanoma patients

Vander Stichele D, Wilgenhof S,Vandenbroucke F, Dufour S, Lienard D, Roseeuw D, del Marmol V, Neyns (Belgium)

 

P035 | Melanoma chemotherapy leads to the selection of ABCB5-expressing cells

Chartrain M, Riond J, Stennevin A, Vandenberghe I, Gomes B, Gairin JE, Guilbaud N, Annereau JP (France)

 

P036 | Malignant melanoma and pregnancy

Somlai B, Hársing J, Bottlik GY (Hungary)

 

P037 | Review: Clinical Multiphoton/CARS tomography of human skin

König K, Breunig G, Sterry W, Büttner E, Lademann J (Germany)

 

P038 | Melanoma, the great mimicry

Fejős Z, Mónos Z, Plotár V, Vajda A (Hungary)

 

P039 | Neonatal blue light phototherapy and melanocytic naevi: a twin study

Oláh J, Csoma Z, Tóth-Molnár E, Balogh K, Széll M, Polyánka H, Orvos H, Ócsai H, Kemény L (Hungary)

 

P040 | Comparison of histological characteristics between metastatic and non-metastatic melanomas

Urbancek S, Cernohorska M, Tomkova J, Mensikova J, Mazalova D (Slovakia)

 

P041 | Electrochemotherapy on human melanoma cells in vitro

Skołucka N, Choromań ska A, Saczko J, Kulbacka J, Kotulska M (Poland)

 

P042 | Heat shock protein 27 is essential for melanoma cell proliferation, migration and chemoresistance

Blunder S, Jerney W, Pehamberger H, Hoeller C, Schicher N (Austria)

 

P043 | Palmar fasciitis and polyarthritis syndrome, a new paraneoplastic syndrome in melanoma

Amini-Adle M, Gagnard A, Tardieu M, Tebib J, Balme B, Thomas L (France)

 

P044 | MC1R gene polymorphisms increase the risk of cutaneous malignant melanoma in Latvia independently of skin type and hair color

Pjanova D, Ozola A, Azarjana K, Donina S, Proboka G, Cema I, Heisele O, Streinerte B, Engele L (Latvia)

 

P045 | The MelGene database: A field synopsis of genetic association studies in cutaneous melanoma

Chatzinasiou F, Lill CM, Spyrou G, Kypreou K, Stefanaki I, Nicolaou V, Evangelou E, Roehr JT, Kodela E, Katsambas A, Tsao H, Ioannidis JPA, Bertram L, Stratigos AJ (Greece, Germany, USA)

 

P046 | High-throughput mRNA profiling of microdissected melanocytes and melanoma cells for the characterization of melanoma predisposition in a swine model

Estellé J, Piton G, Bevilacqua C, Bouet S, Bourneuf E, Leplat JJ, Crechet F, Jaffrezic F, Martin P, Rogel-Gaillard C, Vincent-Naulleau S (France)

 

P047 | Heme oxygenase-1 is a key player in differentiation of melanoma cells

Was H, Tejchman A, Dubiel M, Dominik P, Kotlinowski J, Zebzda A, Dulak J, Jozkowicz A (Poland)

 

P048 | TYRP1 function in melanoma progression

Mogha A, Gilot D, Primot A, Debbache J, Bennett D, Ghanem G, Dreno B, Galibert MD (France, Belgium)

 

 

 

Lymphoma

 

P049 | Lymphomatous meningitis and skin involvement in a case of waldenstrom macroglobulinemia

Valizadeh N (Iran)

 

P050 | Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

Knol AC, Quéreux G, Brocard A, Ballanger F, Nguyen JM, Khammari A, Dréno B (France)

 

P051 | Peripheral anaplastic large cell lymphoma (ALCL) mimicking an antitubercular drug rash–a doubly fatal diagnostic delay

Renita L, Vetrichevvel TP, Adikrishnan S, Krishnakanth M, Murugan S, Mahalakshmi V, Sudha R, Shobana S, Anandan S (India)

 

P052 | Leukemia cutis in an Indian female - A rare entity

Puri N (India)

 

P053 | Lymphomatoid granulomatosis revealed by cutaneous lesions

Quéreux G, Brocard A, Peuvrel L, Knol AC, Renaut JJ, Dréno B (France)

 

P054 | A case of blastic plasmocytoid dendritic cell neoplasm

Lengyel Z, Kajtár B, Nagy A, Battyáni Z (Hungary)

 

P055 | Vesiculobullous lesions in cutaneous T-cell lymphomas: a case report and literature review

Diaconeasa A, Al Khamis S, Chiticariu E, Chiriac A, Solovan C (Romania)

 

P056 | Primary cutaneous peripheral CD8+ T-cell lymphoma

Baili L, Belfekih H, Aydi Z, Ben Dhaou B, Boussema F, Ketari S, Rokbani L (Tunisia)

 

 

 

 

Carcinoma and other tumors

 

P057 | An unusual case of metastatic basal cell carcinoma

Granel-Brocard F, Barbaud A, Schmutz JL (France)

 

P058 | Detection of HPV in situ carcinomas by in situ hybridization after photodynamic therapy

Brocard A, Pelltier-Gloria S, Knol AC, Peuvrel L, Quéreux G, Dréno B (France)

 

P059 | Treatment of a multicentric Merkel cell carcinoma using Imatinib

Peuvrel L, Quéreux G, Brocard A, Dréno B (France)

 

P060 | Role of regulatory T-cells in control of cutaneous squamous cell carcinoma

Vin H, Tsai KY (USA)

 

P061 | 10 years follow-up results after facial basal cell carcinoma treatment in Latvia

Derjabo A, Cema I (Latvia)

 

P062 | Mortality in cancer patients with a history of squamous cell skin cancer - a nationwide population-based cohort study Alba

Johannesdottir S, Lash TL, Østergaard Jensen A, Körmendiné Farkas D, Braae Olesen A (Denmark)

 

P063 | Reconstruction of eyelid defects after cutaneous malignant tumor excision

Baek JH, Chun JH, Kim JW, Yoo DS (South Korea)

 

P064 | Correlation between GST and IL-10 gene polymorphisms and clinical characteristics of patients with basal cell carcinoma

Mijuskovic ZP, Kandolf Sekulovic L, Cikota Aleksic B, Magic Z (Serbia)

 

P065 | Treatment of basal cell carcinoma with Imiquimod 5% cream – Results of 3 years follow-up

Derjabo A, Karls R, Ķisis J (Latvia)

 

P066 | Long-term sustained efficacy of low dose 5-fluorouracil combined with 10% salicylic acid as a lesion directed treatment for actinic keratoses

Stockfleth E, Ulrich M, Kerl H, Willers C (Germany)

 

P067 | Low dose 5-fluorouracil combined with 10% salicylic acid: Characteristics of a topical lesion directed treatment for actinic keratoses

Stockfleth E, Risius I, Ocker WG (Germany)

 

P068 | Sarcomatoid porocarcinoma: integrated surgical-chemo-radio approach

Ribero S, Ponzetti A, Grassi M, Caliendo V, Lauro D, Lista P, Macripò G (Italy)

 

P069 | The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients

Speeckaert R, Brochez L, Lambert J, van Geel N, Speeckaert MM, Claeys L, Langlois M, Van Laer C, Peeters P, Delanghe JR (Belgium)

 

P070 | Necrotizing sialometaplasia of the hard palate associated with bulimia: a rare disease simulating malignancy

Alno N, Carissan A, Le Gall F, Limbour P (France)

 

P071 | Evaluating the outcomes of temporal bone resection in metastatic cutaneous head and neck malignancies

O’Connor A, Kinsella J, Toner M, Beausang E, Timon C (Ireland)

 

P072 | Hidradenocarcinoma with lung metastasis

Hamada S, Khales A, Senouci K, Hassam B (Morocco)

 

P073 | Dermatological follow-up of patients with non melanoma skin cancer after solid organ transplantation switched to an mTOR Inhibitor

Alter M, Satzger I, Kapp A, Gutzmer R (Germany)

 

P074 | Sebaceous carcinoma with unusual location. Case report

Staniceanu F, Zurac S, Andrei R, Tebeica T, Moisa M (Romania)

 

P075 | Histopathologic appearance of nevus sebaceous of Jadassohn

Zurac S, Andrei R, Tebeica T, Staniceanu F, Chitu V, Boda D, Diaconeasa A, Giurcaneanu C (Romania)

 

P076 | Sequential treatment with MAL-PDT and imiquimod (Aldara®) in difficult-to-treat basal cell carcinomas: long-term outcome

Leroy B, Ahbib S, Marot L, Vereecken P (Belgium)

 

P077 | Prognostic factors in squamous cell carcinoma of the skin

Preiml Y, Pehamberger H, Loewe R (Austria)

 

P078 | Dermoscopy of a cutaneous pigmented epidermotropic breast cancer metastasis in a male patient

Triquet G, Bel B, Ervais A, Aubriot MH, Cottin Y, Truc G, Vabres P (France)

 

P079 | Medical corrective make-up lessons: evaluation of quality of life after one month

Peuvrel L, Vallet C, Mère A, Dréno B (France)

 

P080 | Multiple eruptive cellular dermatofibromas

Bernigaud C, Bel B, Ferry D, Petrella T, Calonje E, Vabres P (France, United Kingdom)

 

P081 | Phacomatosis pigmentosa multiplex : long-term follow-up in an adult

Jeudy G, Lambert D, Faivre-Olivier L, Vabres P (France)

 

P082 | Penile metastases as an initial manifestation of a prostatic adenocarcinoma

Bernigaud C, Bel B, Aubriot-Lorton MH, Vabres P (France)